Vivo Capital, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Vivo Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$39.79 - $67.01 $20.1 Million - $33.8 Million	-504,980 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$34.52 - $53.29 $45.2 Million - $69.7 Million	-1,308,360 Reduced 72.15%	504,980 $26 Million
Q4 2018 Feb 13, 2019	SELL	$29.75 - $42.9 $7.03 Million - $10.1 Million	-236,205 Reduced 11.52%	1,813,340 $67.1 Million
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $1.64 Million - $2.51 Million	72,727 Added 3.68%	2,049,545 $52.8 Million
Q3 2017 Nov 13, 2017	BUY	$23.54 - $38.21 $46.5 Million - $75.5 Million	1,976,818	1,976,818 $73.9 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.